Staphylococcal enterotoxin, a bacterial toxin implicated in some ARDS cases, can be prevented by treatment with the cannabis compound THC. Findings also suggest a potential role for using cannabinoids to treat ARDS caused by COVID-19. Read More
Cannabidiol (CBD) increases cerebral blood flow to areas of the brain associated with memory processing, specifically the hippocampus. The findings identify a potential mechanism for the use of CBD to treat disorders associated with altered memory processing, including Alzheimer's disease, PTSD, and schizophrenia. Read More
Cannabis reduces the severity of symptoms by more than half in the short-term for people suffering from PTSD. Using cannabis reduces recurring thoughts of a traumatic event by 62%, flashbacks by 51%, irritability by 67%, and anxiety by 57% for those with PTSD. However, the reduction of symptoms is not permanent. Read More
Hemp oil reduced mechanical pain sensitivity 10-fold within seven hours in mice with chronic postoperative neuropathic pain. Read More
Cannabidiol (CBD) appears to slow the growth of glioblastoma brain cancer cells in both animal and human cell lines. CBD's anti-cancer actions target mitochondria, causing them to dysfunction and release harmful reactive oxygen species. Cancer cells treated with CBD exhibited significant decreases in mitochondrial activity. Read More
Using purified botanical cannabidiol (CBD) to treat mouse models of Davet syndrome improved mortality and reduced behavioral symptoms associated with the condition. Read More
Many cannabis users don't know how much THC or CBD is considered an effective dose. Read More
Ninety percent of medical marijuana products offered at dispensaries are far stronger than recommended for chronic pain relief. Read More
Vaping cannabis products with rich THC content leads to drug-seeking behaviors in animal models. Read More
Analyzing the results of 15 different studies involving over 300 subjects, researchers discovered a single dose of THC could induce psychiatric symptoms in people with no history of psychosis. Read More
Cannabigerol (CBG), a non-psychoactive cannabis compound, has antibiotic potential. Treating mice with MRSA, CBG worked as well as vancomycin, a powerful antibiotic, for treating the infection. Read More
During memory tasks, people with psychosis have different patterns of activity in the prefrontal and mediotemporal brain areas compared to those without the disorder. When exposed to cannabidiol (CBD), the activity of the brain areas became more like those seen in the controls for people with psychosis. Patients reported a decrease in symptoms of psychosis following one dose of CBD. Researchers stress that no definitive conclusions could be made about the effectiveness of CBD use over a sustained period. Read More
